Published in Cancer Weekly, June 30th, 1997
The non-obese diabetic/severe combined immunodeficient (NOD/SCID) xenotransplant model will be an important tool in studies to define the proliferative, differentiative, and self-renewal capacities of primitive human hematopoietic cells, indicated Jean C.Y. Wang, Hospital for Sick Children, Toronto, Canada, and colleagues ("Primitive Human Hematopoietic Cells Are Enriched in Cord Blood Compared with Adult Bone Marrow or Mobilized Peripheral Blood as Measured by the Quantitative In Vivo SCID-Repopulating Cell Assay," Blood, June 1, 1997;89:3919-3924).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.